跳至主要内容
临床试验/NCT00986830
NCT00986830已完成不适用

Healthcare Utilization and Outcomes of FinESS Treatment in the Office

Entellus Medical, Inc.26 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2009年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
74
试验地点
26
主要终点
Sino-Nasal Outcomes Test

研究概览

简要总结

A prospective, nonrandomized trial to evaluate postoperative healthcare resource utilization after maxillary balloon antrostomy using FinESS Sinus Treatment in the physician's office.

详细描述

A prospective, nonrandomized trial to evaluate postoperative healthcare resource utilization after maxillary balloon antrostomy using FinESS Sinus Treatment in the physician's office. Also to demonstrate the long-term durability of FinESS Sinus Treatment performed in an office setting.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • Male or female subjects
  • Diagnosis of rhinosinusitis (CT radiographic evidence and medical evaluation)
  • Willing to comply with protocol requirements
  • Able to provide consent

排除标准

  • Hemophilia
  • Cystic fibrosis
  • Ciliary dysfunction
  • Severe septal deviation causing obstruction of the ostiomeatal unit
  • Pregnant females

结局指标

主要结局

Sino-Nasal Outcomes Test

时间窗: Baseline and 12 months post procedure

The 20-item Sino-Nasal Outcomes Test (SNOT-20) is a validated, disease-specific patient-reported instrument designed to indicate the severity of rhinosinusitis symptoms. The SNOT-20 evaluates 20 symptoms on a scale from 0 ("no problem") to 5 ("problem as bad as it can be"). The overall SNOT-20 score is the average of the 20 symptoms scores providing a range from 0 to 5 with higher scores indicating worse symptoms. The minimal clinically important difference (MCID) has been determined to be a reduction of 0.8 or more in the overall SNOT-20 score.

次要结局

  • Rhinosinusitis Symptom Inventory (RSI) Nasal Symptoms Domain(Baseline and 12 months post procedure)
  • Rhinosinusitis Symptom Inventory (RSI) Facial Symptoms Domain(Baseline and 12 months post procedure)
  • Rhinosinusitis Symptom Inventory (RSI) Oropharyngeal Symptoms Domain(Baseline and 12 months post procedure)
  • Number of Participants With Device and/or Procedure-related Adverse Events(Baseline through 12 months post procedure)
  • Rhinosinusitis Symptom Inventory (RSI) Systemic Symptoms Domain(Baseline and 12 months post procedure)
  • Number of Participants Using Nasal Steroids(Baseline and 12 months post procedure)
  • Number of Participants Using Antihistamines(Baseline and 12 months post procedure)
  • Number of Participants Using Antibiotics(Baseline and 12 months post procedure)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (26)

Loading locations...

相似试验